RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) ("the Company" or "RegeneRx") announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database. RegeneRx has been invited to present at MDB's 2nd Annual Bright Lights Conference to be held at Le Parker Meridien Hotel in New York City on May 10 & 11.
Christopher Marlett, chief executive officer of MDB Capital Group commented by saying, "RegeneRx Biopharma's imbedded IP value and demonstrated innovation places it in the top 10% of the approximately 1500 technology companies trading below $500 million in market value as ranked by our proprietary IP intelligence database called PatentVest. Our research has shown that this elite group of companies demonstrating above average PatentVest metrics, such as PatentVest Tech Score and the compound annual growth rate (CAGR) of patent applications, have significantly outperformed their publicly traded peers. In addition, companies in this group have demonstrated higher margins and more sustained growth."
A link to the PatentVest report on RegeneRx may be found on MDB Capital Group's website at www.mdb.com.
Personality dictates binge-watching: Study reveals why we can't stop streaming